# CBD improves neuropsychiatric symptoms in tuberous sclerosis complex: EpiCom trial insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-neuropsychiatric-symptoms-tuberous-sclerosis-epicom-trial/ > **Published:** 2026-04-21T22:02:05-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:15:42-04:00 > **Clinical Summary:** Explore how CBD neuropsychiatric symptoms tuberous sclerosis treatment shows promise in the EpiCom trial for behavioral and cognitive improvements. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Pediatric NeurologyEpilepsyCbdAutism SpectrumRare Disease Why This Matters Tuberous sclerosis complex affects 1 in 6,000 births and carries devastating neuropsychiatric burden beyond seizures. The EpiCom trial provides the first controlled evidence that CBD may address behavioral symptoms in TSC, potentially offering families a treatment option for one of the most challenging aspects of this condition. Clinical Summary The EpiCom trial evaluated CBD’s effects on neuropsychiatric symptoms in tuberous sclerosis complex patients. TSC commonly presents with autism spectrum behaviors, intellectual disability, and behavioral challenges alongside epilepsy. While CBD has established efficacy for TSC-associated seizures, this study specifically examined its impact on the behavioral and cognitive symptoms that often prove more disabling than seizures themselves. The trial suggests CBD may improve neuropsychiatric outcomes, though the specific mechanisms remain unclear. Dr. Caplan’s Take “This fills a critical gap because families often tell me the behavioral symptoms are harder to manage than the seizures. If CBD can address both seizure control and neuropsychiatric symptoms in TSC, we’re looking at a more comprehensive therapeutic approach for these complex patients.” Clinical Perspective 🧠 Clinicians should recognize that TSC patients may benefit from CBD beyond seizure reduction. When counseling TSC families, discuss both seizure and behavioral endpoints when considering CBD therapy. Monitor for improvements in autism-spectrum behaviors, sleep, and [cognitive function](https://cedclinic.com/reverse-cholesterol-transport-function-cannabis-users/) alongside traditional seizure metrics. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CBD%20improves%20neuropsychiatric%20symptoms%20in%20tuberous%20sclerosis%20complex%3A%20EpiCom%20tri...%20%40drcaplan&url=https%3A//www.vjneurology.com/video/45o8o1tq6x4-cbd-improves-neuropsychiatric-symptoms-in-tuberous-sclerosis-complex-epicom-trial-insights/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.vjneurology.com/video/45o8o1tq6x4-cbd-improves-neuropsychiatric-symptoms-in-tuberous-sclerosis-complex-epicom-trial-insights/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CBD%20improves%20neuropsychiatric%20symptoms%20in%20tuberous%20sclerosis%20complex%3A%20EpiCom%20tri...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.vjneurology.com/video/45o8o1tq6x4-cbd-improves-neuropsychiatric-symptoms-in-tuberous-sclerosis-complex-epicom-trial-insights/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.vjneurology.com/video/45o8o1tq6x4-cbd-improves-neuropsychiatric-symptoms-in-tuberous-sclerosis-complex-epicom-trial-insights/](https://www.vjneurology.com/video/45o8o1tq6x4-cbd-improves-neuropsychiatric-symptoms-in-tuberous-sclerosis-complex-epicom-trial-insights/) Table of Contents - [FAQ](#FAQ)[What medical conditions does this research focus on?](#What_medical_conditions_does_this_research_focus_on) - [What is CBD and how does it relate to cannabis medicine?](#What_is_CBD_and_how_does_it_relate_to_cannabis_medicine) - [Why is this study considered highly clinically relevant?](#Why_is_this_study_considered_highly_clinically_relevant) - [Is CBD treatment safe for children with neurological conditions?](#Is_CBD_treatment_safe_for_children_with_neurological_conditions) - [How might this research impact current treatment approaches?](#How_might_this_research_impact_current_treatment_approaches) - [Related](#Related) ## FAQ #### What medical conditions does this research focus on? This research primarily focuses on pediatric neurological conditions, specifically epilepsy and autism spectrum disorders. The study examines CBD treatment applications for these challenging neurological conditions in children. #### What is CBD and how does it relate to cannabis medicine? CBD (cannabidiol) is a non-psychoactive compound derived from cannabis plants that has shown therapeutic potential for neurological disorders. Unlike THC, CBD does not produce intoxicating effects, making it more suitable for pediatric medical applications. #### Why is this study considered highly clinically relevant? This research has been rated as having high clinical relevance (#80) due to its strong evidence base and direct implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). The findings provide actionable insights that can immediately inform clinical decision-making for pediatric neurological conditions. #### Is CBD treatment safe for children with neurological conditions? CBD has shown a favorable safety profile in pediatric populations when used under medical supervision. However, proper dosing, quality control, and ongoing monitoring by qualified healthcare providers are essential for safe and effective treatment. #### How might this research impact current treatment approaches? This research could influence clinical guidelines and treatment protocols for pediatric epilepsy and autism spectrum disorders. It may provide evidence to support CBD as an adjunctive or [alternative therapy](https://cedclinic.com/cannabis-for-chronic-pelvic-pain-self-management/) option for patients who don’t respond well to conventional treatments. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [WSU study looks at cannabis impacts on memory – YouTube – CED Clinic](https://cedclinic.com/cannabis-memory-cognitive-effects-wsu-study/) Explore research on how cannabis affects different types of memory, providing insights relevant to neuropsychiatric symptom management. [Watch Study Summary](https://cedclinic.com/cannabis-memory-cognitive-effects-wsu-study/) [Cannabinoids for sleep: Could cannabinol be the best option? – Study Summary](https://cedclinic.com/cannabinoid-sleep-research-2026-cannabinol-insights/) Review [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) focusing on sleep improvements, a common neuropsychiatric symptom in tuberous sclerosis complex. [Read Study Summary](https://cedclinic.com/cannabinoid-sleep-research-2026-cannabinol-insights/) [The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) Discover top [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) aimed at enhancing mental clarity and focus, relevant for cognitive symptoms in TSC patients. [Explore CBD Options](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).